This study identified a feature of the epileptic brain that evolves slowly and differs fundamentally in well-controlled and poorly controlled epilepsy.
A diagnosis of maternal epilepsy alone was not associated with an increase in congenital malformations in offspring.
Patients with both MS and epileptic seizures had a younger age at onset of MS compared with those without seizures.
Functional MRI may provide a less-invasive option for evaluating memory function in patients undergoing epilepsy surgery.
Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.
Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.
Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.
Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.
Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.
Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.
Clobazam had been previously identified as an AED with a significant interaction with CBD.
Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.
Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.
The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.
Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.
Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal SclerosisDecember 04, 2016
Atrophy in areas outside of the MTLE-HS network may predict poor surgical outcomes.
Less than 30% of patients were seen by an effective provider within 1 week of onset of infantile spasms.
Half of patients experienced a reduction in seizure frequency after statin initiation.
Awareness of the effects of polypharmacy on patient well-being is an important component of care.
Patients taking cannabidiol experienced a significant reduction in drop seizures compared with placebo.
Michael Privatera, MD, AES president spoke with Neurology Advisor about some of the key topics and presentations slated for this year's meeting.
Veterans with epilepsy could benefit from evidence-based chronic disease self-management programs that target physical and psychiatric comorbidities.
Lack of adherence has been linked to increased risks of intubation and ICU admission.
Those with older age at seizure onset are at the greatest risk for decline in naming ability.
Patients with these EEG characteristics may benefit from early screening and intervention.
The EXIST-3 trial is the first phase 3 study to evaluate the use of EVE for the adjunctive treatment of seizures in TSC.
The drug is the first and only IV formulation of the antiepileptic carbamazepine.
On average, pediatric patients spent more time in the ICU and accounted for a larger hospitalization cost.
Neurology Advisor Articles
- Cannabis: Current Evidence and Research Recommendations
- Addressing Gender Differences in Concussion Diagnosis and Treatment
- Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant
- Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring
- In Stroke, No Clear Benefit for Head Positioning